Pre-announcement: Research call on AMR diagnostics and surveillance
We are pleased to pre‐announce the transnational call “Development of innovative strategies, tools, technologies, and methods for diagnostics and surveillance of antimicrobial resistance”. The call involves 21 funding organisations from 18 countries and has a total estimated call budget of 18,8 M€.
Reports from DESIGN OH AMR consultations available
In 2022, the Coordination and Support Action (CSA) DESIGN OH AMR has organised a series of stakeholder and expert consultations to collect input to the update of the research and innovation objectives within the JPIAMR SRIA.
Survey on funding instruments by the future OH AMR Partnership programme
In preparation for the future OH AMR Partnership, JPIAMR invites the research community to share its view on gaps in the AMR funding landscape and the requirements for potential funding mechanisms with impact.
Main achievements of Therapeutics research projects and networks
A report on the outputs, outcome and impact generated by the projects funded in the various JPIAMR transnational research project and network calls under the Therapeutics priority topic has been published.
Social sciences as a cross-cutting theme in JPIAMR research priorities
The development of resistance to antibiotics is a biological process, but the context that determines emergence and impact of resistance is underpinned by social aspects. Therefore, it is necessary to identify, understand and evaluate these social aspects to enable the prevention and control of AMR.
Consultation: antiparasitic and antiviral resistance
The JPIAMR has launched a round of consultation on antiparasitic and antiviral resistance. The information will be used for outlining research and innovation priorities in the Strategic Research and Innovation Agenda (SRIA) on Antimicrobial Resistance and informing the scope and direction of the candidate One Health AMR partnership.
Review from the JPIAMR SRIA fungal resistance group published in Nature Reviews Microbiology
The review “Tackling the emerging threat of antifungal resistance to human health” has been published in the April edition of Nature Reviews Microbiology. The review was written by the expert group on antifungals that led the broadening on the JPIAMR Strategic Research and Innovation Agenda in 2021.
Strategic Research and Innovation Agenda – global survey
The JPIAMR has launched a round of public consultation on the Strategic Research and Innovation Agenda (SRIA) on Antimicrobial Resistance in preparation for the One Health AMR partnership.
JPIAMR Activity Report 2021
The JPIAMR Activity Report that was published today summarises the JPIAMR achievements and major events for the year 2021.
Research call on drug resistance now open
The transnational project call Disrupting drug resistance using innovative design is now open. The call aims to improve the treatment and/or prevention of bacterial and fungal infections. It involves 27 funding organisations from 18 countries and the total estimated call budget is about 19 million Euro.